{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:16:48Z","timestamp":1789179408418,"version":"build-2803163510"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:00:00Z","timestamp":1760227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:00:00Z","timestamp":1760227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40265-025-02240-7","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T14:59:13Z","timestamp":1760281153000},"page":"1565-1583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current and Emerging Treatments for Acid Sphingomyelinase Deficiency"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4891-2686","authenticated-orcid":false,"given":"Tamires","family":"Silva Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lu\u00edza","family":"Fonseca Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-3686","authenticated-orcid":false,"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,12]]},"reference":[{"issue":"5","key":"2240_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s10545-007-0632-9","volume":"30","author":"EH Schuchman","year":"2007","unstructured":"Schuchman EH. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-pick disease. J Inherit Metab Dis. 2007;30(5):654\u201363. https:\/\/doi.org\/10.1007\/s10545-007-0632-9.","journal-title":"J Inherit Metab Dis"},{"key":"2240_CR2","unstructured":"Wasserstein MP, Schuchman EH. Acid sphingomyelinase deficiency. 2006 Dec 7 [updated 2023 Apr 27]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae. Seattle (WA): University of Washington: p. 1993\u20132025."},{"issue":"8","key":"2240_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s40265-022-01727-x","volume":"82","author":"SJ Keam","year":"2022","unstructured":"Keam SJ. Olipudase alfa: first approval. Drugs. 2022;82(8):941\u20137. https:\/\/doi.org\/10.1007\/s40265-022-01727-x.","journal-title":"Drugs"},{"key":"2240_CR4","first-page":"1","volume":"79","author":"A Niemann","year":"1914","unstructured":"Niemann A. Ein unbekanntes Krankheitsbild. Jahrb Kinderheilkd. 1914;79:1.","journal-title":"Jahrb Kinderheilkd"},{"key":"2240_CR5","first-page":"1483","volume":"23","author":"L Pick","year":"1927","unstructured":"Pick L. Uber die lipoidzellige splenohepatomegalie typus Niemann-Pick als stoffwechselerkrankung. Med Klin. 1927;23:1483.","journal-title":"Med Klin"},{"issue":"3","key":"2240_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/archinte.1927.00130030141014","volume":"39","author":"W Bloom","year":"1927","unstructured":"Bloom W, Kern R. Spleens from Gaucher\u2019s disease and lipoid-histiocytosis: the chemical analysis. Arch Intern Med (Chic). 1927;39(3):456\u201361. https:\/\/doi.org\/10.1001\/archinte.1927.00130030141014.","journal-title":"Arch Intern Med (Chic)"},{"key":"2240_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1515\/bchm2.1934.229.4-6.151","volume":"229","author":"E Klenk","year":"1934","unstructured":"Klenk E. \u00dcber die natur der phosphatide der milz bei der Niemann-Pickschen krankheit. Hoppe Seylers Z Physiol Chem. 1934;229:151\u20136. https:\/\/doi.org\/10.1515\/bchm2.1934.229.4-6.151.","journal-title":"Hoppe Seylers Z Physiol Chem"},{"issue":"1","key":"2240_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-195802000-00001","volume":"37","author":"AC Crocker","year":"1958","unstructured":"Crocker AC, Farber S. Niemann-Pick disease: a review of eighteen patients. Medicine (Baltimore). 1958;37(1):1\u201395. https:\/\/doi.org\/10.1097\/00005792-195802000-00001.","journal-title":"Medicine (Baltimore)"},{"key":"2240_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1471-4159.1961.tb13499.x","volume":"7","author":"AC Crocker","year":"1961","unstructured":"Crocker AC. The cerebral defect in Tay-Sachs disease and Niemann-Pick disease. J Neurochem. 1961;7:69\u201380. https:\/\/doi.org\/10.1111\/j.1471-4159.1961.tb13499.x.","journal-title":"J Neurochem"},{"issue":"2","key":"2240_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1073\/pnas.55.2.366","volume":"55","author":"RO Brady","year":"1966","unstructured":"Brady RO, Kanfer JN, Mock MB, Fredrickson DS. The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc Natl Acad Sci U S A. 1966;55(2):366\u20139. https:\/\/doi.org\/10.1073\/pnas.55.2.366.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2240_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/0006-291x(69)90777-3","volume":"34","author":"HR Sloan","year":"1969","unstructured":"Sloan HR, Uhlendorf BW, Kanfer JN, Brady RO, Fredrickson DS. Deficiency of sphingomyelin-cleaving enzyme activity in tissue cultures derived from patients with Niemann-Pick disease. Biochem Biophys Res Commun. 1969;34(5):582\u20138. https:\/\/doi.org\/10.1016\/0006-291x(69)90777-3.","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"2240_CR12","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1073\/pnas.82.23.8247","volume":"82","author":"PG Pentchev","year":"1985","unstructured":"Pentchev PG, Comly ME, Kruth HS, Vanier MT, Wenger DA, Patel S, et al. A defect in cholesterol esterification in Niemann-pick disease (type C) patients. Proc Natl Acad Sci U S A. 1985;82(23):8247\u201351. https:\/\/doi.org\/10.1073\/pnas.82.23.8247.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2240_CR13","doi-asserted-by":"publisher","first-page":"8531","DOI":"10.1016\/S0021-9258(18)93007-3","volume":"266","author":"EH Schuchman","year":"1991","unstructured":"Schuchman EH, Suchi M, Takahashi T, Sandhoff K, Desnick RJ. Human acid sphingomyelinase: isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J Biol Chem. 1991;266(13):8531\u20139.","journal-title":"J Biol Chem"},{"issue":"2","key":"2240_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0888-7543(91)90246-b","volume":"9","author":"L da Veiga Pereira","year":"1991","unstructured":"da Veiga Pereira L, Desnick RJ, Adler DA, Disteche CM, Schuchman EH. Regional assignment of the human acid sphingomyelinase gene (SMPD1) by PCR analysis of somatic cell hybrids and in situ hybridization to 11p15.1\u2013\u2013p15.4. Genomics. 1991;9(2):229\u201334. https:\/\/doi.org\/10.1016\/0888-7543(91)90246-b.","journal-title":"Genomics"},{"issue":"5323","key":"2240_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1126\/science.277.5323.228","volume":"277","author":"OP Diggelen","year":"1997","unstructured":"Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, et al. Niemann-pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 1997;277(5323):228\u201331. https:\/\/doi.org\/10.1126\/science.277.5323.228.","journal-title":"Science"},{"issue":"5500","key":"2240_CR16","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1126\/science.290.5500.2298","volume":"290","author":"S Naureckiene","year":"2000","unstructured":"Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 2000;290(5500):2298\u2013301. https:\/\/doi.org\/10.1126\/science.290.5500.2298.","journal-title":"Science"},{"issue":"1","key":"2240_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02686-6","volume":"18","author":"T Geberhiwot","year":"2023","unstructured":"Geberhiwot T, Wasserstein M, Wanninayake S, Bolton SC, Dardis A, Lehman A, et al. Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-pick disease types A, B and A\/B). Orphanet J Rare Dis. 2023;18(1):85. https:\/\/doi.org\/10.1186\/s13023-023-02686-6.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2240_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1089\/gte.1997.1.13","volume":"1","author":"EH Schuchman","year":"1997","unstructured":"Schuchman EH, Miranda SR. Niemann-Pick disease: mutation update, genotype\/phenotype correlations, and prospects for genetic testing. Genet Test. 1997;1(1):13\u20139. https:\/\/doi.org\/10.1089\/gte.1997.1.13.","journal-title":"Genet Test"},{"issue":"8","key":"2240_CR19","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1182\/blood.V80.8.2081.2081","volume":"80","author":"O Levran","year":"1992","unstructured":"Levran O, Desnick RJ, Schuchman EH. Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients. Blood. 1992;80(8):2081\u20137.","journal-title":"Blood"},{"issue":"9","key":"2240_CR20","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1073\/pnas.88.9.3748","volume":"88","author":"O Levran","year":"1991","unstructured":"Levran O, Desnick RJ, Schuchman EH. Niemann-pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients. Proc Natl Acad Sci U S A. 1991;88(9):3748\u201352. https:\/\/doi.org\/10.1073\/pnas.88.9.3748.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2240_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/humu.1380020414","volume":"2","author":"O Levran","year":"1993","unstructured":"Levran O, Desnick RJ, Schuchman EH. Type A Niemann-Pick disease: a frameshift mutation in the acid sphingomyelinase gene (fsP330) occurs in Ashkenazi Jewish patients. Hum Mutat. 1993;2(4):317\u20139. https:\/\/doi.org\/10.1002\/humu.1380020414.","journal-title":"Hum Mutat"},{"issue":"6","key":"2240_CR22","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1086\/345074","volume":"71","author":"CM Simonaro","year":"2002","unstructured":"Simonaro CM, Desnick RJ, McGovern MM, Wasserstein MP, Schuchman EH. The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype\/phenotype correlations. Am J Hum Genet. 2002;71(6):1413\u20139. https:\/\/doi.org\/10.1086\/345074.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2240_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF01247328","volume":"92","author":"MT Vanier","year":"1993","unstructured":"Vanier MT, Ferlinz K, Rousson R, Duthel S, Louisot P, Sandhoff K, et al. Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-pick disease type B patients from northern Africa. Hum Genet. 1993;92(4):325\u201330. https:\/\/doi.org\/10.1007\/BF01247328.","journal-title":"Hum Genet"},{"issue":"5","key":"2240_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.revmed.2016.10.387","volume":"38","author":"O Lidove","year":"2017","unstructured":"Lidove O, Belmatoug N, Froissart R, Lavigne C, Durieu I, Mazodier K, et al. D\u00e9ficit en sphingomy\u00e9linase acide (maladie de Niemann-Pick B): une \u00e9tude r\u00e9trospective multicentrique de 28 patients adultes. Rev Med Interne. 2017;38(5):291\u20139. https:\/\/doi.org\/10.1016\/j.revmed.2016.10.387.","journal-title":"Rev Med Interne"},{"issue":"7","key":"2240_CR25","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/humu.21018","volume":"30","author":"L Rodr\u00edguez-Pascau","year":"2009","unstructured":"Rodr\u00edguez-Pascau L, Gort L, Schuchman EH, Vilageliu L, Grinberg D, Chab\u00e1s A. Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients. Hum Mutat. 2009;30(7):1117\u201322. https:\/\/doi.org\/10.1002\/humu.21018.","journal-title":"Hum Mutat"},{"issue":"3","key":"2240_CR26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ymgme.2012.06.015","volume":"107","author":"CE Hollak","year":"2012","unstructured":"Hollak CE, de Sonnaville ES, Cassiman D, Linthorst GE, Groener JE, Morava E, et al. Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients. Mol Genet Metab. 2012;107(3):526\u201333. https:\/\/doi.org\/10.1016\/j.ymgme.2012.06.015.","journal-title":"Mol Genet Metab"},{"key":"2240_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13023-021-01842-0","volume":"16","author":"MM McGovern","year":"2021","unstructured":"McGovern MM, Wasserstein MP, Bembi B, et al. Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation. Orphanet J Rare Dis. 2021;16:212. https:\/\/doi.org\/10.1186\/s13023-021-01842-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2240_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ejhg.2015.89","volume":"24","author":"M Acu\u00f1a","year":"2016","unstructured":"Acu\u00f1a M, Mart\u00ednez P, Moraga C, He X, Moraga M, Hunter B, et al. Epidemiological, clinical and biochemical characterization of the p. (Ala359Asp) SMPD1 variant causing Niemann-Pick disease type B. Eur J Hum Genet. 2016;24(2):208\u201313. https:\/\/doi.org\/10.1038\/ejhg.2015.89.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"2240_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10545-005-5671-5","volume":"28","author":"H Pavl\u016f-Pereira","year":"2005","unstructured":"Pavl\u016f-Pereira H, Asfaw B, Poupctov\u00e1 H, Ledvinov\u00e1 J, Sikora J, Vanier MT, et al. Acid sphingomyelinase deficiency: phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis. 2005;28(2):203\u201327. https:\/\/doi.org\/10.1007\/s10545-005-5671-5.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"2240_CR30","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/humu.24192","volume":"42","author":"J Hu","year":"2021","unstructured":"Hu J, Maegawa GHB, Zhan X, Gao X, Wang Y, Xu F, et al. Clinical, biochemical, and genotype-phenotype correlations of 118 patients with Niemann-Pick disease types A\/B. Hum Mutat. 2021;42(5):614\u201325. https:\/\/doi.org\/10.1002\/humu.24192.","journal-title":"Hum Mutat"},{"issue":"2","key":"2240_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.beem.2014.08.004","volume":"29","author":"SD Kingma","year":"2015","unstructured":"Kingma SD, Bodamer OA, Wijburg FA. Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening. Best Pract Res Clin Endocrinol Metab. 2015;29(2):145\u201357. https:\/\/doi.org\/10.1016\/j.beem.2014.08.004.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"2240_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/gim.2017.7","volume":"19","author":"MM McGovern","year":"2017","unstructured":"McGovern MM, Dionisi-Vici C, Giugliani R, Hwu P, Lidove O, Lukacs Z, et al. Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency. Genet Med. 2017;19(9):967\u201374. https:\/\/doi.org\/10.1038\/gim.2017.7.","journal-title":"Genet Med"},{"issue":"Apr","key":"2240_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.dld.2019.12.005","volume":"52","author":"F Nascimbeni","year":"2020","unstructured":"Nascimbeni F, Dionisi Vici C, Vespasiani Gentilucci U, Angelico F, Nobili V, Petta S, et al. AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement. Dig Liver Dis. 2020;52(Apr):359\u201367. https:\/\/doi.org\/10.1016\/j.dld.2019.12.005.","journal-title":"Dig Liver Dis"},{"issue":"23","key":"2240_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312870","volume":"22","author":"C Pinto","year":"2021","unstructured":"Pinto C, Sousa D, Ghilas V, Dardis A, Scarpa M, Macedo MF. Acid sphingomyelinase deficiency: a clinical and immunological perspective. Int J Mol Sci. 2021;22(23):12870. https:\/\/doi.org\/10.3390\/ijms222312870.","journal-title":"Int J Mol Sci"},{"key":"2240_CR35","unstructured":"Schuchman EH, Desnick RJ. Niemann-Pick disease types A and B: acid sphingomyelinase deficiencies. In: Valle DL, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA, editors. The online metabolic and molecular bases of inherited disease. McGraw-Hill Education; 2019. 2025. Available from: https:\/\/ommbid.mhmedical.com\/content.aspx?bookid=2709&sectionid=225545671. Accessed 8 Sep 2025."},{"issue":"6","key":"2240_CR36","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/jimd.12780","volume":"47","author":"RE Hickey","year":"2024","unstructured":"Hickey RE, Baker J. Newborn screening for acid sphingomyelinase deficiency in Illinois: a single center\u2019s experience. J Inherit Metab Dis. 2024;47(6):1363\u201370. https:\/\/doi.org\/10.1002\/jimd.12780.","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"2240_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2023.107654","volume":"140","author":"F Kubaski","year":"2023","unstructured":"Kubaski F, Sousa I, Amorim T, Pereira D, Silva C, Chaves V, et al. Pilot study of newborn screening for six lysosomal diseases in Brazil. Mol Genet Metab. 2023;140(1\u20132):107654. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107654.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"2240_CR38","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/jcm13051465","volume":"13","author":"T Jerves Serrano","year":"2024","unstructured":"Jerves Serrano T, Gold J, Cooper JA, Church HJ, Tylee KL, Wu HY, et al. Hepatomegaly and splenomegaly: an approach to the diagnosis of lysosomal storage diseases. J Clin Med. 2024;13(5):1465. https:\/\/doi.org\/10.3390\/jcm13051465.","journal-title":"J Clin Med"},{"issue":"1","key":"2240_CR39","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1038\/s41598-021-82296-z","volume":"11","author":"I Motta","year":"2021","unstructured":"Motta I, Consonni D, Stroppiano M, et al. Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia. Sci Rep. 2021;11(1):2594. https:\/\/doi.org\/10.1038\/s41598-021-82296-z.","journal-title":"Sci Rep"},{"issue":"3","key":"2240_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ymgme.2016.12.003","volume":"120","author":"E Mengel","year":"2017","unstructured":"Mengel E, Pineda M, Hendriksz CJ, Walterfang M, Torres JV, Kolb SA. Differences in Niemann-Pick disease type C symptomatology observed in patients of different ages. Mol Genet Metab. 2017;120(3):180\u20139. https:\/\/doi.org\/10.1016\/j.ymgme.2016.12.003.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"2240_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5546\/aap.2017.eng.287","volume":"115","author":"L Bay","year":"2017","unstructured":"Bay L, Canero Velasco C, Ciocca M, et al. Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D): clinical and diagnostic aspects, and a new treatment. An update. Arch Argent Pediatr. 2017;115(3):287\u201393. https:\/\/doi.org\/10.5546\/aap.2017.eng.287.","journal-title":"Arch Argent Pediatr"},{"issue":"3","key":"2240_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ymgme.2016.05.001","volume":"118","author":"D Cassiman","year":"2016","unstructured":"Cassiman D, Packman S, Bembi B, et al. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): literature review and report of new cases [published correction appears in Mol Genet Metab. 2018 Dec;125(4):360. 10.1016\/j.ymgme.2017.09.005.]. Mol Genet Metab. 2016;118(3):206\u201313. https:\/\/doi.org\/10.1016\/j.ymgme.2016.05.001.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2240_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1179\/1607845414Y.0000000161","volume":"20","author":"BL Gaspar","year":"2014","unstructured":"Gaspar BL, Sharma P, Das R. Anemia in malignancies: pathogenetic and diagnostic considerations. Hematology. 2014;20(1):18\u201325. https:\/\/doi.org\/10.1179\/1607845414Y.0000000161.","journal-title":"Hematology"},{"issue":"1","key":"2240_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpeds.2004.02.048","volume":"145","author":"MM McGovern","year":"2004","unstructured":"McGovern MM, Pohl-Worgall T, Deckelbaum RJ, Simpson W, Mendelson D, Desnick RJ, et al. Lipid abnormalities in children with types A and B Niemann Pick disease. J Pediatr. 2004;145(1):77\u201381. https:\/\/doi.org\/10.1016\/j.jpeds.2004.02.048.","journal-title":"J Pediatr"},{"issue":"12","key":"2240_CR45","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/ppul.20725","volume":"42","author":"N Guillemot","year":"2007","unstructured":"Guillemot N, Troadec C, de Villemeur TB, Cl\u00e9ment A, Fauroux B. Lung disease in Niemann-pick disease. Pediatr Pulmonol. 2007;42(12):1207\u201314. https:\/\/doi.org\/10.1002\/ppul.20725.","journal-title":"Pediatr Pulmonol"},{"issue":"160","key":"2240_CR46","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0363-2020","volume":"30","author":"R Borie","year":"2021","unstructured":"Borie R, Crestani B, Guyard A, Lidove O. Interstitial lung disease in lysosomal storage disorders. Eur Respir Rev. 2021;30(160):200363. https:\/\/doi.org\/10.1183\/16000617.0363-2020.","journal-title":"Eur Respir Rev"},{"issue":"4","key":"2240_CR47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ymgme.2021.06.009","volume":"133","author":"U Ramaswami","year":"2021","unstructured":"Ramaswami U, Mengel E, Berrah A, et al. Throwing a spotlight on under-recognized manifestations of Gaucher disease: pulmonary involvement, lymphadenopathy and Gaucheroma. Mol Genet Metab. 2021;133(4):335\u201344. https:\/\/doi.org\/10.1016\/j.ymgme.2021.06.009.","journal-title":"Mol Genet Metab"},{"key":"2240_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13665-012-0029-6","volume":"1","author":"A Gogali","year":"2012","unstructured":"Gogali A, Wells AU. Diagnostic approach to interstitial lung disease. Curr Respir Care Rep. 2012;1:199\u2013207. https:\/\/doi.org\/10.1007\/s13665-012-0029-6.","journal-title":"Curr Respir Care Rep"},{"issue":"2","key":"2240_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1212\/01.wnl.0000194208.08904.0c","volume":"66","author":"MM McGovern","year":"2006","unstructured":"McGovern MM, Aron A, Brodie SE, Desnick RJ, Wasserstein MP. Natural history of type A Niemann-Pick disease: possible endpoints for therapeutic trials. Neurology. 2006;66(2):228\u201332. https:\/\/doi.org\/10.1212\/01.wnl.0000194208.08904.0c.","journal-title":"Neurology"},{"issue":"1","key":"2240_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0572-x","volume":"12","author":"MM McGovern","year":"2017","unstructured":"McGovern MM, Avetisyan R, Sanson BJ, Lidove O. Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD). Orphanet J Rare Dis. 2017;12(1):41. https:\/\/doi.org\/10.1186\/s13023-017-0572-x.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2240_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/biom14020211","volume":"14","author":"C Tirelli","year":"2024","unstructured":"Tirelli C, Rondinone O, Italia M, Mira S, Belmonte LA, De Grassi M, et al. The genetic basis, lung involvement, and therapeutic options in Niemann-Pick disease: a comprehensive review. Biomolecules. 2024;14(2):211. https:\/\/doi.org\/10.3390\/biom14020211.","journal-title":"Biomolecules"},{"issue":"6","key":"2240_CR52","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1542\/peds.2004-0887","volume":"114","author":"MP Wasserstein","year":"2004","unstructured":"Wasserstein MP, Desnick RJ, Schuchman EH, Hossain S, Wallenstein S, Lamm C, et al. The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study. Pediatrics. 2004;114(6):e672\u20137. https:\/\/doi.org\/10.1542\/peds.2004-0887.","journal-title":"Pediatrics"},{"issue":"2","key":"2240_CR53","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1542\/peds.2007-3016","volume":"122","author":"MM McGovern","year":"2008","unstructured":"McGovern MM, Wasserstein MP, Giugliani R, Bembi B, Vanier MT, Mengel E, et al. A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B. Pediatrics. 2008;122(2):e341\u20139. https:\/\/doi.org\/10.1542\/peds.2007-3016.","journal-title":"Pediatrics"},{"issue":"4","key":"2240_CR54","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jpeds.2006.06.034","volume":"149","author":"MP Wasserstein","year":"2006","unstructured":"Wasserstein MP, Aron A, Brodie SE, Simonaro C, Desnick RJ, McGovern MM. Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease. J Pediatr. 2006;149(4):554\u20139. https:\/\/doi.org\/10.1016\/j.jpeds.2006.06.034.","journal-title":"J Pediatr"},{"key":"2240_CR55","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/diagnostics15070804","volume":"15","author":"RM Vlad","year":"2025","unstructured":"Vlad RM, Dobritoiu R, Pacurar D. From genes to treatment: literature review and perspectives on acid sphingomyelinase deficiency in children. Diagnostics. 2025;15:804. https:\/\/doi.org\/10.3390\/diagnostics15070804.","journal-title":"Diagnostics"},{"issue":"2","key":"2240_CR56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ymgme.2018.11.014","volume":"126","author":"M Wasserstein","year":"2019","unstructured":"Wasserstein M, Dionisi-Vici C, Giugliani R, et al. Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD). Mol Genet Metab. 2019;126(2):98\u2013105. https:\/\/doi.org\/10.1016\/j.ymgme.2018.11.014.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"2240_CR57","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/gim.2013.4","volume":"15","author":"MM McGovern","year":"2013","unstructured":"McGovern MM, Lippa N, Bagiella E, Schuchman EH, Desnick RJ, Wasserstein MP. Morbidity and mortality in type B Niemann-Pick disease. Genet Med. 2013;15(8):618\u201323. https:\/\/doi.org\/10.1038\/gim.2013.4.","journal-title":"Genet Med"},{"issue":"10","key":"2240_CR58","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.transproceed.2015.10.051","volume":"47","author":"GR Coelho","year":"2015","unstructured":"Coelho GR, Praciano AM, Rodrigues JP, Viana CF, Brand\u00e3o KP, Valenca JT Jr, et al. Liver transplantation in patients with Niemann-Pick disease-single-center experience. Transplant Proc. 2015;47(10):2929\u201331. https:\/\/doi.org\/10.1016\/j.transproceed.2015.10.051.","journal-title":"Transplant Proc"},{"issue":"3","key":"2240_CR59","doi-asserted-by":"publisher","first-page":"498","DOI":"10.21037\/hbsn-21-454","volume":"11","author":"H Ding","year":"2022","unstructured":"Ding H, Wang J, Zhang Y, Zhao S, Han B, Cai H, et al. Living donor liver transplantation combined with splenectomy in a child with Niemann-Pick disease type B: single-centre experience of perioperative anticoagulation regimen. Hepatobiliary Surg Nutr. 2022;11(3):498\u2013501. https:\/\/doi.org\/10.21037\/hbsn-21-454.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"8","key":"2240_CR60","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/lt.25457","volume":"25","author":"Y Liu","year":"2019","unstructured":"Liu Y, Luo Y, Xia L, Qiu B, Zhou T, Feng M, et al. The effects of liver transplantation in children with Niemann-Pick disease type B. Liver Transpl. 2019;25(8):1233\u201340. https:\/\/doi.org\/10.1002\/lt.25457.","journal-title":"Liver Transpl"},{"issue":"4","key":"2240_CR61","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1542\/peds.2005-0867","volume":"116","author":"AJ Shah","year":"2005","unstructured":"Shah AJ, Kapoor N, Crooks GM, Parkman R, Weinberg KI, Wilson K, et al. Successful hematopoietic stem cell transplantation for Niemann-Pick disease type B. Pediatrics. 2005;116(4):1022\u20135. https:\/\/doi.org\/10.1542\/peds.2005-0867.","journal-title":"Pediatrics"},{"issue":"7","key":"2240_CR62","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/pbc.21300","volume":"49","author":"J Schneiderman","year":"2007","unstructured":"Schneiderman J, Thormann K, Charrow J, Kletzel M. Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann-pick type B. Pediatr Blood Cancer. 2007;49(7):987\u20139. https:\/\/doi.org\/10.1002\/pbc.21300.","journal-title":"Pediatr Blood Cancer"},{"key":"2240_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26811","author":"P Quarello","year":"2018","unstructured":"Quarello P, Spada M, Porta F, Vassallo E, Timeus F, Fagioli F. Hematopoietic stem cell transplantation in Niemann-Pick disease type B monitored by chitotriosidase activity. Pediatr Blood Cancer. 2018. https:\/\/doi.org\/10.1002\/pbc.26811.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2240_CR64","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.healun.2018.10.002","volume":"38","author":"H Mannem","year":"2019","unstructured":"Mannem H, Kilbourne S, Weder M. Lung transplantation in a patient with Niemann-pick disease. J Heart Lung Transplant. 2019;38(1):100\u20131. https:\/\/doi.org\/10.1016\/j.healun.2018.10.002.","journal-title":"J Heart Lung Transplant"},{"key":"2240_CR65","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9431751","volume":"2019","author":"RS O\u2019Neill","year":"2019","unstructured":"O\u2019Neill RS, Belousova N, Malouf MA. Pulmonary type B Niemann-pick disease successfully treated with lung transplantation. Case Rep Transplant. 2019;2019:9431751. https:\/\/doi.org\/10.1155\/2019\/9431751.","journal-title":"Case Rep Transplant"},{"issue":"5","key":"2240_CR66","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.healun.2019.01.002","volume":"38","author":"F Ding","year":"2019","unstructured":"Ding F, Mehta AC, Arrossi AV. Successful lung transplantation in a patient with Niemann-pick disease. J Heart Lung Transplant. 2019;38(5):582\u20133. https:\/\/doi.org\/10.1016\/j.healun.2019.01.002.","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"2240_CR67","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1016\/j.chest.2020.11.074","volume":"159","author":"C Tirelli","year":"2021","unstructured":"Tirelli C, Arbustini E, Meloni F. Bilateral cystic bronchiectasis as novel phenotype of Niemann-Pick disease type B successfully treated with double lung transplantation. Chest. 2021;159(5):e293\u20137. https:\/\/doi.org\/10.1016\/j.chest.2020.11.074.","journal-title":"Chest"},{"key":"2240_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5428381","volume":"2022","author":"VMC Mora","year":"2022","unstructured":"Mora VMC, Osorio JSC, Iturbe DF, Tello SM, Guzm\u00e1n YG, S\u00e1nchez LM, et al. Double-lung transplantation in a patient with pulmonary type B Niemann-Pick disease: a valid treatment option. Case Rep Transplant. 2022;2022:5428381. https:\/\/doi.org\/10.1155\/2022\/5428381.","journal-title":"Case Rep Transplant"},{"issue":"3","key":"2240_CR69","first-page":"123","volume":"5","author":"WHO Drug Information","year":"1991","unstructured":"WHO Drug Information. Alglucerase for Gaucher\u2019s disease: regulatory matters. WHO Drug Inf. 1991;5(3):123\u20134.","journal-title":"WHO Drug Inf"},{"issue":"21","key":"2240_CR70","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","volume":"324","author":"NW Barton","year":"1991","unstructured":"Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, et al. Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease. N Engl J Med. 1991;324(21):1464\u201370. https:\/\/doi.org\/10.1056\/NEJM199105233242104.","journal-title":"N Engl J Med"},{"issue":"1","key":"2240_CR71","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/dmcn.13600","volume":"60","author":"M Beck","year":"2018","unstructured":"Beck M. Treatment strategies for lysosomal storage disorders. Dev Med Child Neurol. 2018;60(1):13\u20138. https:\/\/doi.org\/10.1111\/dmcn.13600.","journal-title":"Dev Med Child Neurol"},{"key":"2240_CR72","unstructured":"US Food and Drug Administration. FDA approves first treatment for acid sphingomyelinase deficiency, a rare genetic disease [press release]. 31 August, 2022. Available from: https:\/\/www.prnewswire.com\/news-releases\/fda-approves-first-treatment-for-acid-sphingomyelinase-deficiency-a-rare-genetic-disease-301615726.html. Accessed 19 Jan 2025."},{"key":"2240_CR73","unstructured":"European Medicines Agency. First therapy to treat two types of Niemann-Pick disease, a rare genetic metabolic disorder [press release]. 20 May, 2022. Available from: https:\/\/www.ema.europa.eu\/en\/news\/first-therapy-treat-two-types-niemann-pick-disease-rare-genetic-metabolic-disorder. Accessed 19 Jan 2025."},{"key":"2240_CR74","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Xenpozyme (alfaolipudase): novo registro [press release]. 19 September, 2022. Available from: https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/medicamentos\/novos-medicamentos-e-indicacoes\/xenpozyme-alfaolipudase-novo-registro#:~:text=)%3A%20novo%20registro-,Xenpozyme%20(alfaolipudase)%3A%20novo%20registro,A%2FB%20ou%20tipo%20B. Accessed 19 Jan 2025."},{"issue":"2","key":"2240_CR75","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/s0167-4838(99)00069-2","volume":"1432","author":"X He","year":"1999","unstructured":"He X, Miranda SR, Xiong X, Dagan A, Gatt S, Schuchman EH. Characterization of human acid sphingomyelinase purified from the media of overexpressing Chinese hamster ovary cells. Biochim Biophys Acta. 1999;1432(2):251\u201364. https:\/\/doi.org\/10.1016\/s0167-4838(99)00069-2.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2240_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.gimo.2023.100780","volume":"1","author":"M Penon-Portmann","year":"2023","unstructured":"Penon-Portmann M, Poskanzer SA, Ganesh J, Chang I, ACMG Therapeutics Committee. Olipudase alfa approved for pediatric and adult patients with acid sphingomyelinase deficiency (ASMD): a therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genet Med Open. 2023;1(1):100780. https:\/\/doi.org\/10.1016\/j.gimo.2023.100780.","journal-title":"Genet Med Open"},{"issue":"13","key":"2240_CR77","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1096\/fj.00-0014com","volume":"14","author":"SR Miranda","year":"2000","unstructured":"Miranda SR, He X, Simonaro CM, Gatt S, Dagan A, Desnick RJ, et al. Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology. FASEB J. 2000;14(13):1988\u201395. https:\/\/doi.org\/10.1096\/fj.00-0014com.","journal-title":"FASEB J"},{"issue":"3","key":"2240_CR78","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ng0795-288","volume":"10","author":"K Horinouchi","year":"1995","unstructured":"Horinouchi K, Erlich S, Perl DP, Ferlinz K, Bisgaier CL, Sandhoff K, et al. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet. 1995;10(3):288\u201393. https:\/\/doi.org\/10.1038\/ng0795-288.","journal-title":"Nat Genet"},{"issue":"2","key":"2240_CR79","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ymgme.2014.07.005","volume":"114","author":"JM Murray","year":"2015","unstructured":"Murray JM, Thompson AM, Vitsky A, Hawes M, Chuang WL, Pacheco J, et al. Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: the utility of animal models of disease in the toxicological evaluation of potential therapeutics. Mol Genet Metab. 2015;114(2):217\u201325. https:\/\/doi.org\/10.1016\/j.ymgme.2014.07.005.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2240_CR80","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/gim.2015.24","volume":"18","author":"MM McGovern","year":"2016","unstructured":"McGovern MM, Wasserstein MP, Kirmse B, et al. Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency). Genet Med. 2016;18(1):34\u201340. https:\/\/doi.org\/10.1038\/gim.2015.24.","journal-title":"Genet Med"},{"issue":"1\u20132","key":"2240_CR81","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ymgme.2015.05.013","volume":"116","author":"MP Wasserstein","year":"2015","unstructured":"Wasserstein MP, Jones SA, Soran H, Diaz GA, Lippa N, Thurberg BL, et al. Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency. Mol Genet Metab. 2015;116(1\u20132):88\u201397. https:\/\/doi.org\/10.1016\/j.ymgme.2015.05.013.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2240_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02700-x","volume":"18","author":"RH Lachmann","year":"2023","unstructured":"Lachmann RH, Diaz GA, Wasserstein MP, Armstrong NM, Yarramaneni A, Kim Y, et al. Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults. Orphanet J Rare Dis. 2023;18(1):94. https:\/\/doi.org\/10.1186\/s13023-023-02700-x.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"2240_CR83","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.gim.2022.03.021","volume":"24","author":"M Wasserstein","year":"2022","unstructured":"Wasserstein M, Lachmann R, Hollak C, Arash-Kaps L, Barbato A, Gallagher RC, et al. A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: one-year results. Genet Med. 2022;24(7):1425\u201336. https:\/\/doi.org\/10.1016\/j.gim.2022.03.021.","journal-title":"Genet Med"},{"issue":"8","key":"2240_CR84","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41436-021-01156-3","volume":"23","author":"GA Diaz","year":"2021","unstructured":"Diaz GA, Jones SA, Scarpa M, Mengel KE, Giugliani R, Guffon N, et al. One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency. Genet Med. 2021;23(8):1543\u201350. https:\/\/doi.org\/10.1038\/s41436-021-01156-3.","journal-title":"Genet Med"},{"issue":"1","key":"2240_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02983-0","volume":"18","author":"M Wasserstein","year":"2023","unstructured":"Wasserstein M, Lachmann R, Hollak C, Barbato A, Gallagher R, Giugliani R, et al. Continued improvement in disease manifestations of acid sphingomyelinase deficiency for adults with up to 2 years of olipudase alfa treatment: open-label extension of the ASCEND trial. Orphanet J Rare Dis. 2023;18(1):378. https:\/\/doi.org\/10.1186\/s13023-023-02983-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2240_CR86","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s13023-022-02587-0","volume":"17","author":"GA Diaz","year":"2022","unstructured":"Diaz GA, Giugliani R, Guffon N, Jones SA, Mengel E, Scarpa M, et al. Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results. Orphanet J Rare Dis. 2022;17(1):437. https:\/\/doi.org\/10.1186\/s13023-022-02587-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2240_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12789","volume":"48","author":"ECB Eskes","year":"2025","unstructured":"Eskes ECB, van Dussen L, Brands MMMG, Vaz FM, Aerts JMFG, van Kuilenburg ABP, et al. Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: a first step toward treatment criteria. J Inherit Metab Dis. 2025;48(1):e12789. https:\/\/doi.org\/10.1002\/jimd.12789.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2240_CR88","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13023-024-03020-4","volume":"19","author":"EM Raebel","year":"2024","unstructured":"Raebel EM, Wiseman S, Donnelly C, Mathieson T, Pountney J, Crowe J, et al. Real-life impacts of olipudase alfa: the experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiency. Orphanet J Rare Dis. 2024;19(1):36. https:\/\/doi.org\/10.1186\/s13023-024-03020-4.","journal-title":"Orphanet J Rare Dis"},{"issue":"7280","key":"2240_CR89","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature08710","volume":"463","author":"T Kirkegaard","year":"2010","unstructured":"Kirkegaard T, Roth AG, Petersen NH, Mahalka AK, Olsen OD, Moilanen I, et al. Hsp70 stabilizes lysosomes and reverts Niemann-pick disease-associated lysosomal pathology. Nature. 2010;463(7280):549\u201353. https:\/\/doi.org\/10.1038\/nature08710.","journal-title":"Nature"},{"issue":"4","key":"2240_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05784-2","volume":"14","author":"\u00c1 Gaudioso","year":"2023","unstructured":"Gaudioso \u00c1, Jiang X, Casas J, Schuchman EH, Ledesma MD. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency. Cell Death Dis. 2023;14(4):248. https:\/\/doi.org\/10.1038\/s41419-023-05784-2.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2240_CR91","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911776","volume":"12","author":"A Bartoll","year":"2020","unstructured":"Bartoll A, Toledano-Zaragoza A, Casas J, Guzm\u00e1n M, Schuchman EH, Ledesma MD. Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling. EMBO Mol Med. 2020;12(11):e11776. https:\/\/doi.org\/10.15252\/emmm.201911776.","journal-title":"EMBO Mol Med"},{"issue":"20","key":"2240_CR92","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/sj.gt.3301300","volume":"7","author":"SRP Miranda","year":"2000","unstructured":"Miranda SRP, Erlich S, Friedrich VL Jr, Gatt S, Schuchman EH. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease. Gene Ther. 2000;7(20):1768\u201376. https:\/\/doi.org\/10.1038\/sj.gt.3301300.","journal-title":"Gene Ther"},{"issue":"49","key":"2240_CR93","doi-asserted-by":"publisher","first-page":"17822","DOI":"10.1073\/pnas.0509062102","volume":"102","author":"JC Dodge","year":"2005","unstructured":"Dodge JC, Clarke J, Song A, Bu J, Yang W, Taksir TV, et al. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease. Proc Natl Acad Sci U S A. 2005;102(49):17822\u20137. https:\/\/doi.org\/10.1073\/pnas.0509062102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2240_CR94","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1089\/hum.2010.040","volume":"21","author":"EA Salegio","year":"2010","unstructured":"Salegio EA, Kells AP, Richardson RM, Hadaczek P, Forsayeth J, Bringas J, et al. Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders. Hum Gene Ther. 2010;21(9):1093\u2013103. https:\/\/doi.org\/10.1089\/hum.2010.040.","journal-title":"Hum Gene Ther"},{"issue":"8","key":"2240_CR95","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/hum.2012.052","volume":"23","author":"EA Salegio","year":"2012","unstructured":"Salegio EA, Samaranch L, Jenkins RW, Clarke CJ, Lamarre C, Beyer J, et al. Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain. Hum Gene Ther. 2012;23(8):891\u2013902. https:\/\/doi.org\/10.1089\/hum.2012.052.","journal-title":"Hum Gene Ther"},{"issue":"506","key":"2240_CR96","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat3738","volume":"11","author":"L Samaranch","year":"2019","unstructured":"Samaranch L, P\u00e9rez-Ca\u00f1am\u00e1s A, Soto-Huelin B, Sudhakar V, Jurado-Arjona J, Hadaczek P, et al. Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type A. Sci Transl Med. 2019;11(506):eaat3738. https:\/\/doi.org\/10.1126\/scitranslmed.aat3738.","journal-title":"Sci Transl Med"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-025-02240-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-025-02240-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-025-02240-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:34:08Z","timestamp":1763044448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-025-02240-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,12]]},"references-count":96,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2240"],"URL":"https:\/\/doi.org\/10.1007\/s40265-025-02240-7","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,12]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tamires Silva Alves, Ana Lu\u00edza Fonseca Siqueira and Roberto Giugliani have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"All data reported are available in the references provided.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"As this is a review article, ethical approval was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The family of the patient reported in Fig.\n                      \n                      provided consent to publish the photographs.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors were involved equally in the writing of the first draft and revising the final document. All authors have read and approved the final version of the manuscript, and agree to be accountable for the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}